TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI October 1, 1999